The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.